Clinical Trial Update: Assess Reacto- and Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up Schedule [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating reactogenicity and immunogenicity of a pneumococcal conjugate vaccine when given as a booster or in a two-dose catch-up sche…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infectious Disease
• Pneumococcal Infections
• Streptococcal Infections

Drugs mentioned

• Pneumococcal conjugate vaccine (pneumococcal conjugate vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Streptococcal | Phase 2 | Status: COMPLETED | Results posted: 2009-08-11